Rapid Novor Dx's EasyM™ is a non-invasive, blood-based MRD test for MM, tracking unique M-protein peptides via mass spectrometry for precise monitoring.easym.com Kitchener, OntarioJoined April 2025
We’re marching for @MyelomaCanada on September 28th at the Multiple Myeloma March, and we’re over halfway to our fundraising goal!
✨ Big news: On Sept 26 at 2 p.m. ET, every donation will be matched. That means your gift goes twice as far to support patients and families…
Why MRD Matters in Multiple Myeloma from @bdermanmd :
Read this excellent summary by Dr. Derman on the evolving role of MRD in multiple myeloma and what it could mean for patient care.
Key takeaways:
- MRD negativity is a stronger predictor of outcomes than traditional…
🚨 IMS 2025 Abstracts are Live!
We’re excited to share EasyM’s latest research in Multiple Myeloma:
PA-189: Peripheral Residual Disease (PRD) Monitoring by Clonotypic Mass Spectrometry (EasyM) in Newly Diagnosed Multiple Myeloma
PA-196: Clinical Utility of Quantitative, Mass…
🩸 September is Blood Cancer Awareness Month 🩸
Did you know Multiple Myeloma is the 2nd most common blood cancer in the world?
This month and always, we pledge to:
- Stand with patients and families
- Raise awareness of Multiple Myeloma
- Drive research forward
Every share,…
Help Us Reach Our Fundraising Goal for @MyelomaCanada !
On September 28th, we’ll be walking in the Myeloma Canada Multiple Myeloma March and we’re more than halfway to our fundraising target!
Exciting News: Matching Gift Alert!
On September 26th at 2 p.m. ET, every donation…
For patients who are MRD positive, the MIDAS trial tested two different treatment approaches, and the outcomes were similar. This suggests MRD is a powerful marker that may help guide personalized treatment decisions in newly diagnosed multiple myeloma.
@jmikhaelmd#AskTheIMF
It's almost Blood Cancer Awareness Month, and it's time myeloma got the spotlight. Learn more about this blood cancer and create your own custom graphic to spread awareness at knowmyeloma.org When we work together, it's easy to support the myeloma community! #KnowMyeloma
🩸 SOHO 2025 is next week!
Looking forward to this talk:
First-in-Human Study of JNJ-79635322 (JNJ-5322), A Novel Next-Generation Trispecific Antibody, in Patients With Relapsed/Refractory Multiple Myeloma: Initial Phase 1 Results
Presenter: Hans Lee, MD
With the growing…
Got questions about Mass Spec MRD?
Drop your questions below and our expert team will answer them!
Mass spectrometry is emerging as a powerful tool for measurable residual disease (MRD) detection in multiple myeloma, more sensitive, precise, and able to distinguish treatment…
📣 Poll Results Are In!
We asked Oncologists and Hematologists: “When does MRD testing offer the most critical insight in managing multiple myeloma?”
100% of respondents pointed to Maintenance Monitoring as the key area where MRD can deliver the greatest impact.
This reflects…
Double Your Impact for Myeloma Canada | Myélome Canada 🩸
We’re walking on September 28th for the Myeloma Canada Multiple Myeloma March and we’re halfway to our fundraising goal!
Special Matching Gift Alert:
On September 26 at 2 p.m. ET, every dollar you give will be matched…
Looking forward to the #SOHO2025 debate lead by @RobertOrlowski on Frontline + Maintenance Guided by MRD!
Surging evidence supports MRD adapted therapy:
MRD2STOP: Patients with sustained MRD-negativity could stop maintenance and maintain remission, reducing treatment burden.…
MRD Insights from the CASSIOPEIA Trial 📢
A new analysis from the landmark CASSIOPEIA study confirms what many myeloma experts have been saying:
Deeper, longer lasting MRD negativity = longer progression free survival (PFS)
Key Findings:
- Adding daratumumab to induction,…
Quadruplets are now standard upfront for transplant patients, dual maintenance is expanding, MRD is guiding transplant needs, and high-risk patients benefit from continuous aggressive therapy. #AsktheIMF@jmikhaelmd
536 Followers 533 FollowingBhuvan Kishore,Haematologist,BMT, Birmingham UK, myeloma doctor #mmsm
#UHBHaematology, Kolkata born;
Spire Parkway and Spire Little Aston Hospitals
17K Followers 4K FollowingImproving the quality of life of myeloma patients while working toward prevention & cure by focusing on four key areas: research, education, support, & advocacy
408 Followers 689 FollowingTony Award-winner with two Grammy-winning cast albums. He’s an entertainer, entrepreneur, producer, host & fundraiser on The V Foundation board & proud Father.
744 Followers 3K Following"Blind belief in authority is the greatest enemy of truth." ~ Albert Einstein. “If you can’t question it, it’s not science, it’s propaganda.” - @DiscoStew66
241 Followers 1K FollowingDad, Oiler fan, SBG Edmonton blue belt, Podcast listener, Heavy Civil Construction guy........trying to find the balance point between order and chaos.
3K Followers 4K FollowingJesus is the Only Way 🐶Dogs are the best people #AmericaFirst #TurnOffteLIEvision #ItsAllAboutTheChildren #CanineCancer #CureAML
0 Followers 212 FollowingChristian-Blessed Wife-Proud Mother of 3 - Dog Mom-Pro Law Enforcement-Love of the Great Outdoors-Harley-Davidson Rider-Believer in Freedom
112 Followers 44 FollowingProfessor of Hematology -University of Milano, Director of Hematology dept. Istituto Nazionale dei Tumori Milano, President of the Italian Society of Hematology
81 Followers 86 FollowingCardiac RN, MM (PCL) patient, IMF Support Group Leader, Health Tree Coach, Patient Advocate ~ Fighting the fight and trying to help others do the same!
90 Followers 218 FollowingResearch immunologist focused on immunotherapy for #multiplemyeloma @MayoClinic Arizona | Cancer Immunology | Mom, Wife, She/her | Views are my own🔬🧬🏃♀️
67 Followers 281 FollowingPhysician scientist working on multiple myeloma @SanRaffaeleMI @MyUniSR. Passionate about cancer cell biology and its translational potential.
20K Followers 3K FollowingProfessor, Leukemia; Executive Director-Cancer Medicine for MDACC Cancer Network | Director #BPDCN Program | #MPNSM #leusm #TeamPemm | Tweets:my own opinions
848 Followers 218 FollowingPhysician scientist @BrighamHeme and @DFCI. Former @BrighamMedRes. Heme malignancy. Clonal hematopoiesis. Multiple myeloma. Live in Boston but root for LA.
1K Followers 171 FollowingClinical Care Options creates innovative, interactive #Oncology #CME programs. Follow us to be the first to know when content is published.
10K Followers 3K FollowingFollow us for updates on the latest American Cancer Society research to help prevent, fight and cure cancer.
https://t.co/Y9sAPyOasI
536 Followers 533 FollowingBhuvan Kishore,Haematologist,BMT, Birmingham UK, myeloma doctor #mmsm
#UHBHaematology, Kolkata born;
Spire Parkway and Spire Little Aston Hospitals
31K Followers 4K FollowingAn interdisciplinary international journal of the American Cancer Society. Editor-in-Chief: Suresh S. Ramalingam, MD (@RamalingamMD)
112K Followers 2K FollowingThe mission of the American Association for Cancer Research is to prevent and cure cancer through research, education, communication, and collaboration.
5K Followers 857 FollowingMD-PhD; Radiation oncologist with a passion for health equity; addressing health literacy; loving patients & advocates; empowering individuals & communities.
16K Followers 766 FollowingWe innovate with purpose to lead where medicine is going. Channel run by Janssen Global Services LLC, NJ, USA. Our community guidelines: https://t.co/aMAhBk9BBJ
543 Followers 201 FollowingPhysician-Scientist running a hypothesis-driven research program to develop effective therapies for Amyloidosis and Myeloma patients. @brighamheme @harvardmed